The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease

Intensive Versus Conventional Therapy to Slow the Progression of Idiopathic Glomerular Diseases

(2010) Stefano Bianchi et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Serum Potassium and Outcomes in CKD: Insights from the RRI-CKD Cohort Study

(2010) S. Korgaonkar et al.   Clinical Journal of the American Society of Nephrology

Predictors of Hyperkalemia Risk following Hypertension Control with Aldosterone Blockade

(2009) Nitin Khosla et al.   AMERICAN JOURNAL OF NEPHROLOGY

Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease

(2009) Nicola C. Edwards et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular effects of aldosterone blockade in CKD

(2009) Bertram Pitt   Nature Reviews Cardiology

Change in Proteinuria After Adding Aldosterone Blockers to ACE Inhibitors or Angiotensin Receptor Blockers in CKD: A Systematic Review

(2008) Andrew S. Bomback et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Renal aspirin: will all patients with chronic kidney disease one day take spironolactone?

(2008) Andrew S Bomback et al.   Nature clinical practice. Nephrology